Related Experiment Video
Updated: Jul 16, 2026
12:36
Murine Precision-Cut Liver Slices as an Ex Vivo Model of Liver Biology
Published on: March 14, 2020
Pediatric liver disease.
1Guy's, King's and St. Thomas' School of Medicine, London, UK.
Current Opinion in Gastroenterology
|October 7, 2006
Summary
Pediatric hepatology advances improve survival for children with severe liver disease. Research has clarified intrahepatic cholestasis and paved the way for liver gene therapy.
Area of Science:
- Hepatology
- Pediatric Gastroenterology
- Genetics
- Immunology
Background:
- Pediatric hepatology has seen significant advancements, leading to improved survival rates for children with severe liver disease into adulthood.
- Research has focused on conditions unique to pediatric practice, yielding notable breakthroughs.
- Intrahepatic cholestasis disorders have been significantly elucidated, enhancing understanding of hepatic physiology.
Purpose of the Study:
- To summarize recent advancements in pediatric hepatology.
- To highlight progress in understanding intrahepatic cholestasis and hepatic physiology.
- To discuss the emerging potential of liver-directed gene therapy and hepatocyte transplantation.
Main Methods:
- Review of recent research findings in pediatric liver disease.
- Elucidation of genetic and immunological factors in liver disorders.
- Development and application of animal models and isolated hepatocyte transplantation.
Main Results:
- Substantial unraveling of intrahepatic cholestasis disorders, contributing to hepatic physiology knowledge.
- Progress towards human application of liver-directed gene therapy.
- Advancements facilitated by improved animal models and hepatocyte transplantation techniques.
Conclusions:
- Recent research has significantly advanced the understanding of pediatric liver diseases, particularly intrahepatic cholestasis.
- Liver-directed gene therapy and hepatocyte transplantation are on the cusp of clinical application.
- Further research in genetics and immunology holds promise for future therapeutic advances in conditions like biliary atresia and viral hepatitis.
More Related Videos
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...